- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04913493
Use of Sublingual Microcirculation and FloTrac Monitoring During Major Vascular Surgery and Its Effect on Hospital LOS
Use of Sublingual Microcirculation and FloTrac Monitoring During Major Vascular Surgery and Its Effect on Hospital Length of Stay: a Prospective Cohort Study
the aim of this study is to determine whether an intraoperative optimization protocol using the enhanced flow-based hemodynamic parameters of the FloTrac/Vigileo device in combination with intraoperative measurement of the sublingual microcirculation with the Cytocam-IDF device would result in an improvement in outcome in high-risk patients undergoing major vascular surgery, measured by the hospital LOS in comparison with intraoperative FloTrac/Vigileo monitoring alone.
The FloTrac/Vigileo device only needs standard arterial access for enhanced, flow-based hemodynamic monitoring. It is reported to be easy to use and easy to set up and calculates the stroke volume (SV) on the basis of the arterial waveform in combination with demographic data. Cardiac index (CI), stroke volume index (SVI) as an indicator for fluid status and stroke volume variation (SVV) as an indicator for fluid responsiveness during mechanical ventilation and sinus rhythm will be continuously measured during major vascular procedures, including carotid endarterectomy (CEA), open abdominal aortic aneurysm (AAA) repair , endovascular aneurysm repair (EVAR), thoracic endovascular aneurysm repair (TEVAR) and fenestrated endovascular aneurysm repair (FEVAR).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Brussel
-
Jette, Brussel, Belgium, 1090
- UZ Brussel
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18 years
- Males and females
- ASA III classification
- Written informed consent obtained by the patient
- Elective hospital admission for major vascular surgery procedures (CEA, open AAA, EVAR, TEVAR, FEVAR)
Exclusion Criteria:
- Age < 18 years
- Presence of permanent cardiac arrythmias
- Weight < 55kg and > 140kg
- Pregnancy
- Emergency surgery
- Minor vascular procedures
- Refusal or inability to provide written informed consent (language barrier, mental retardation, dementia)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Patients will only receive FloTrac/Vigileo monitoring which is standard of care.
|
|
Experimental: Experimental group
Patients will receive an additional medical imaging intervention.
Namely sublingual microcirculation imaging with Cytocam-IDF.
|
Patients receive an extra medical imaging test perioperatively with the Cytocam-IDF
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of hospitalisation days. (LOS)
Time Frame: up to 30 Days
|
How long is the hospital Length-Of-Stay?
|
up to 30 Days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hélène De Cuyper, MD, Universitair Ziekenhuis Brussel
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FLOMIC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carotid Artery Plaque
-
University Hospital OstravaCharles University, Czech Republic; University Hospital Olomouc; University of... and other collaboratorsActive, not recruiting
-
Cambridge University Hospitals NHS Foundation TrustNot yet recruitingCarotid Artery Plaque | Carotid Atherosclerosis | TIAUnited Kingdom
-
Marc van SambeekEindhoven University of TechnologyUnknown
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingCarotid Artery Plaque | Carotid Stenosis | Carotid Artery Diseases | Carotid Atherosclerosis | Atheroma; Carotid ArteryFrance
-
Canadian Medical and Surgical Knowledge Translation...AmgenRecruitingCarotid Artery Stenosis | Asymptomatic Carotid Artery StenosisCanada
-
Xuanwu Hospital, BeijingRecruitingCarotid Artery Plaque | Carotid Artery Stenting | Carotid EndarterectomyChina
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCarotid Artery Plaque | Carotid Stenosis | Plaque, AtheroscleroticUnited States
-
Arizona Heart InstituteVolcano CorporationCompletedCarotid Artery DiseaseUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Plaque, Atherosclerotic | Immune Checkpoint Inhibitors | Programmed Cell Death Protein 1 Inhibitor | Intimal Medial Thickness of Internal Carotid ArteryChina
-
Heinrich-Heine University, DuesseldorfRecruitingCarotid Artery Plaque | Carotid Artery Diseases | Carotid Artery Stenosis Asymptomatic | Carotid Artery StenosisGermany
Clinical Trials on Cytocam-IDF
-
Universitair Ziekenhuis BrusselWithdrawnSurgery--ComplicationsBelgium
-
Medical Centre LeeuwardenCompletedSurgery | Hypovolemic ShockNetherlands
-
Cairo UniversityRecruiting
-
University of VirginiaWithdrawnPregnancy | EclampsiaUnited States
-
LG Life SciencesCompleted
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1 | FastingEgypt
-
LG Life SciencesCompleted
-
LG Life SciencesCompleted
-
LG Life SciencesCompleted
-
National Institute of Cardiology, Laranjeiras,...RecruitingHeart Valve Diseases | Extracorporeal Circulation | Microvascular RarefactionBrazil